From the Journals

NASH rapidly overtaking hepatitis C as cause of liver cancer


 

FROM THE JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY


“Histologically, NASH shares characteristics with alcoholic liver disease, primarily proinflammatory fat accumulation in parenchymal cells, [and] key players in NASH progression to HCC are suggested to include genetic modifications, proinflammatory high-fat and/or high-fructose diets, and oxidative and endoplasmic cellular stresses,” they wrote. “In HCV progression to HCC, the presence of the HCV core protein may induce HCC without the prerequisite load of genetic errors normally required for cancer development, skipping or accelerating some of the classic steps of cancer induction.”

The authors did note that their model represented a base scenario that assumed the environmental and genetic factors driving NASH would continue along the path of current trends.

“Therefore, the possibility exists that our models underestimate the response of the medical community in addressing the rising nonalcoholic fatty liver disease/NASH epidemic.”

No funding sources or conflicts of interest were declared.

SOURCE: Ahmed O et al. J Clin Exp Hepatology. 2018 Feb 24. doi: 10.1016/j.jceh.2018.02.006.

Pages

Recommended Reading

Elevated liver cancer risk after HCV cure may justify surveillance
MDedge Hematology and Oncology
Hepatitis infection raises non-Hodgkin lymphoma risk in HIV patients
MDedge Hematology and Oncology
Study found no link between direct-acting antivirals, hepatocellular carcinoma
MDedge Hematology and Oncology
SNP predicts liver cancer in hepatitis C patients regardless of SVR
MDedge Hematology and Oncology
Tumor boards linked to improved survival in hepatocellular carcinoma
MDedge Hematology and Oncology
HCV patients with early-stage hepatocellular carcinoma can achieve SVR
MDedge Hematology and Oncology
Genetics dictate interferon-alfa diarrhea risk
MDedge Hematology and Oncology
Antiviral medication successful for treating HCV in hepatocellular carcinoma
MDedge Hematology and Oncology
State regulations for tattoo facilities increased blood donor pools
MDedge Hematology and Oncology
Denmark reinstates ID NAT screening for blood donations
MDedge Hematology and Oncology